Harvard researcher Dr. David Sinclair has found himself at the center of controversy within the longevity community. Sinclair has been a poster child of the longevity movement for years.

Harvard geneticist David Sinclair’s seductive notion that aging is a treatable disease has helped companies he founded to raise more than $1 billion. The investors have almost nothing to show ...